Study results may give the company an edge in the battle for market share in aortic stenosis. First, a bit of background 1.5 million American patients suffer from aortic stenosis, or the narrowing of ...

NEWBURY, England--(BUSINESS WIRE)--Edwards Lifesciences announced new data from the COMMENCE aortic trial, demonstrating low rates of structural valve deterioration (SVD) in bioprosthetic aortic ...

Company Receives CE Mark Approval for 29 mm Transfemoral System First Human Experience With Next-Generation Valve Platforms to Be Presented PARIS-- Edwards Lifesciences Corporation, the global leader ...

IRVINE, CA, Edwards Lifesciences Corporation, the global leader in the science of heart valves and hemodynamic monitoring, today announced that it has received approval from the United States Food and ...

Considering Medtronic (NYSE:MDT) is five times the size of Edwards Lifesciences (NYSE:EW) it probably shouldn’t be receiving the drubbing on transcatheter aortic valves that its smaller rival is ...

Medtronic is emerging as the key rival to Edwards Lifesciences for a new type of heart valve Orange County is shaping up to be the stage for a two-horse race for a new type of heart valve. Last month, ...